Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders-Reference-Cited by-同舟云学术

Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders

Published:2021-06-01 Issue:6 Volume:157 Page:691
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Silverberg Jonathan I.¹,Simpson Eric L.²,Wollenberg Andreas³,Bissonnette Robert⁴,Kabashima Kenji⁵⁶,DeLozier Amy M.⁷,Sun Luna⁷,Cardillo Tracy⁷,Nunes Fabio P.⁸⁹,Reich Kristian¹⁰

Affiliation:

1. Department of Dermatology, George Washington University School of Medicine, Washington, DC

2. Department of Dermatology, Oregon Health & Science University, Portland

3. Department of Dermatology and Allergy, Ludwig Maximillian University, Munich, Germany

4. Innovaderm Research, Montreal, Quebec, Canada

5. Department of Dermatology, Kyoto University, Graduate School of Medicine, Kyoto, Japan

6. Skin Research Institute of Singapore and Singapore Immunology Network, A*Star, Singapore

7. Eli Lilly and Company, Indianapolis, Indiana

8. now with Janssen, Titusville, New Jersey

9. at the time of the trial, Eli Lilly and Company, Indianapolis, Indiana

10. Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2779639/jamadermatology_silverberg_2021_oi_210018_1623774318.15957.pdf

Reference13 articles.

1. Atopic dermatitis.;Langan;Lancet,2020

2. Treatment-resistant atopic dermatitis: challenges and solutions.;Johnson;Clin Cosmet Investig Dermatol,2019

3. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.;Wollenberg;J Eur Acad Dermatol Venereol,2020

4. Guidelines of care for the management of atopic dermatitis: section 3—management and treatment with phototherapy and systemic agents.;Sidbury;J Am Acad Dermatol,2014

5. New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines.;Renert-Yuval;Ann Allergy Asthma Immunol,2020

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates;Dermatology and Therapy;2024-08-22

2. Revisiting immunotherapeutic strategies for the management of atopic dermatitis;Exploration of Asthma & Allergy;2024-08-09

3. Oral Janus Kinase Inhibitors in Pediatric Atopic Dermatitis;Current Allergy and Asthma Reports;2024-08-06

4. Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA);Italian Journal of Dermatology and Venereology;2024-05

5. A case of palmoplantar pustulosis with atopic dermatitis: Baricitinib is a safe and effective treatment;Indian Journal of Dermatology, Venereology and Leprology;2024-04-23